Teva Pharmaceutical Industries Limited:企業のM&A・事業提携・投資動向

◆英語タイトル:Teva Pharmaceutical Industries Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C2132
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:94
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Teva Pharmaceutical Industries Limited – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Teva Pharmaceutical Industries Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Teva Pharmaceutical Industries Limited since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Teva Pharmaceutical Industries Limited’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Teva Pharmaceutical Industries Limited. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Teva Pharmaceutical Industries Limited’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Teva Pharmaceutical Industries Limited and its subsidiaries since 2007.
- Information about key financial and legal advisors for Teva Pharmaceutical Industries Limited’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Teva Pharmaceutical Industries Limited’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
PARTNERSHIP 8
Partnership – Overview 8
Partnership – Deal reports 9
CAPITAL RAISING 27
Capital Raising – Overview 27
Capital Raising – Deal reports 28
DIVESTMENTS 36
Divestments – Overview 36
Divestments – Deal reports 37
PRIVATE EQUITY & OWNERSHIP 59
Private Equity and Ownership – Overview 59
Private Equity and Ownership – Deal reports 60
APPENDIX 84
Contact Us 84
About MarketLine Financial Deals Database 84
Deal Definition and Methodology 86
About MarketLine 93

List of Tables
Table 1: Teva Pharmaceutical Industries Ltd partnership volume and value trend (2014-YTD2018)
Table 2: Teva Pharmaceutical Industries Ltd partnership trend by key deal type (2014-YTD2018)
Table 3: Teva Pharmaceutical Industries Ltd capital raising volume and value trend (2014-YTD2018)
Table 4: Teva Pharmaceutical Industries Ltd capital raising by deal type (2014-YTD2018)
Table 5: Teva Pharmaceutical Industries Ltd divestments volume and value trend (2014-YTD2018)
Table 6: Teva Pharmaceutical Industries Ltd divestments activity by geography (2014-YTD2018)
Table 7: Teva Pharmaceutical Industries Ltd private equity and ownership volume and value trend (2014-YTD2018)
Table 8: Teva Pharmaceutical Industries Ltd private equity and ownership activity by deal type (2014-YTD2018)

List of Figures
Figure 1: Teva Pharmaceutical Industries Ltd partnership volume and value trend (2014-YTD2018)
Figure 2: Teva Pharmaceutical Industries Ltd partnership trend by key deal type (2014-YTD2018)
Figure 3: Teva Pharmaceutical Industries Ltd capital raising volume and value trend (2014-YTD2018)
Figure 4: Teva Pharmaceutical Industries Ltd capital raising by deal type (2014-YTD2018)
Figure 5: Teva Pharmaceutical Industries Ltd divestments volume and value trend (2014-YTD2018)
Figure 6: Teva Pharmaceutical Industries Ltd divestments by geography (2014-YTD2018)
Figure 7: Teva Pharmaceutical Industries Ltd private equity and ownership volume and value trend (2014-YTD2018)
Figure 8: Teva Pharmaceutical Industries Ltd private equity and ownership by deal type (2014-YTD2018)

★海外企業調査レポート[Teva Pharmaceutical Industries Limited:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • European Medical Contract Manufacturing BV:医療機器:M&Aディール及び事業提携情報
    Summary European Medical Contract Manufacturing BV (EMCM BV), a subsidiary of Leader Biomedical Group, is a developer and manufacturer of sterile medicinal products. The company’s products include bone cements for hip and knee arthroplasty and vertebroplasty procedures; cement restrictors; human bon …
  • Transgenomic Inc (TBIO)-医療機器分野:企業M&A・提携分析
    Summary Transgenomic Inc (Transgenomic) is a developer and provider of diagnostic tools and services. The company’s products include ICEme Kits, and genetic assays and platforms. It offers genetic assays and platforms such as PCR reagents, chromatography, genetic analysis kits, hanabi cytogenetic sy …
  • SteadyMed Therapeutics Inc:製品パイプライン分析
    Summary SteadyMed Therapeutics Inc (SteadyMed), a subsidiary of SteadyMed Ltd is a pharmaceutical company that develops and commercializes therapeutic product candidates. The company provides patchpump, a customizable, pre-filled, and pre-programmed disposable parenteral delivery platform for large …
  • FDC Ltd (FDC):企業の財務・戦略的SWOT分析
    Summary FDC Ltd (FDC) is a pharmaceutical company that manufactures and markets of oral rehydration salts, ophthalmics and functional foods. The company also provides active pharmaceuticals ingredients (APIs). It provides products for the therapeutic segments of anti-infectives, gastrointestinals, o …
  • McGill University-製薬・医療分野:企業M&A・提携分析
    Summary McGill University (McGill) is a research based educational institute. The university offers undergraduate, graduate and post-graduate courses. It provides academic courses across various disciplines including agricultural and environmental sciences, arts, dentistry, education, engineering, l …
  • Rockefeller University-製薬・医療分野:企業M&A・提携分析
    Summary Rockefeller University (Rockefeller) is a biomedical research university that provides graduate and postdoctoral educational programs. The university offers various educational courses in the fields of biomedical sciences, chemistry, bioinformatics and physics. It conducts clinical studies i …
  • Lightstream Resources Ltd. (LTS)-石油・ガス分野:企業M&A・提携分析
    Summary Lightstream Resources Ltd. (Lightstream) is an upstream energy company that carries out the acquisition, exploration, development and production of oil and natural gas reserves with a focus on light oil. Its main operating areas include the Bakken and Mississippian formations, Cardium format …
  • American Outdoor Brands Corporation:戦略・SWOT・企業財務分析
    American Outdoor Brands Corporation - Strategy, SWOT and Corporate Finance Report Summary American Outdoor Brands Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Tata Motors Limited:企業の戦略・SWOT・財務分析
    Tata Motors Limited - Strategy, SWOT and Corporate Finance Report Summary Tata Motors Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Midas Group Ltd:企業の戦略・SWOT・財務情報
    Midas Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Midas Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Integrated DNA Technologies Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Integrated DNA Technologies Inc (IDT) is a biotechnology company that develops diagnostic test products. The company’s products include DNA and RNA synthesis, genotyping, modifications, nextgen sequencing, gene silencing, synthesis genes, and purifications, among others. It offers services s …
  • Evoqua Water Technologies Corp (AQUA):企業の財務・戦略的SWOT分析
    Evoqua Water Technologies Corp (AQUA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Dana Petroleum Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Dana Petroleum Ltd (Dana), a wholly-owned subsidiary of Korea National Oil Corp (KNOC), is an upstream oil and gas company. It explores, develops and produces oil and gas from its assets in the Europe and the Middle East. The company has interests and operations in the UK, the Netherlands, D …
  • First Financial Bancorp:企業の戦略・SWOT・財務情報
    First Financial Bancorp - Strategy, SWOT and Corporate Finance Report Summary First Financial Bancorp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Humana Inc (HUM):製薬・医療:M&Aディール及び事業提携情報
    Summary Humana Inc (Humana) is a health and well-being company that offers health insurance and Medicare plans, insurance products, and health and wellness services to healthcare providers, employers, individuals, administrators, government, and the public sector. The company’s Medicare products and …
  • E-CO Energi Holding AS-エネルギー分野:企業M&A・提携分析
    Summary E-CO Energi Holding AS (E-CO Energi) owned by the City of Oslo is an energy company. It owns, operates and develops hydroelectric plants. The company is the second largest hydropower producer in Norway. E-CO Energi also carries out the business development in energy and related fields. The c …
  • Kuzbasskaya Toplivnaya Company:企業の戦略・SWOT・財務分析
    Kuzbasskaya Toplivnaya Company - Strategy, SWOT and Corporate Finance Report Summary Kuzbasskaya Toplivnaya Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Control4 Corp (CTRL):企業の財務・戦略的SWOT分析
    Control4 Corp (CTRL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Mylan Laboratories Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Mylan Laboratories Ltd (Mylan), a subsidiary of Mylan NV is a pharmaceutical company that manufactures and supplies API products. The company offers HIV care products for the treatment of HIV/AIDS. It provides women’s care products for therapies such as hormone replacement therapy, infertili …
  • The SPAR Group Limited:戦略・SWOT・企業財務分析
    The SPAR Group Limited - Strategy, SWOT and Corporate Finance Report Summary The SPAR Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆